ATE495246T1 - Neuartiger shuttle-vektor - Google Patents

Neuartiger shuttle-vektor

Info

Publication number: ATE495246T1
Authority: AT; Austria
Prior art keywords: escherichia coli; region; shuttle vector; ptb6; expression vector
Prior art date: 2004-11-24

Application number

AT09003552T

Other languages

English (en)

Inventor

Yasunobu Kano

Yoshinori Hamaji

Minoru Fujimori

Takayuki Sasaki

Kyoko Kohno

Jun Amano

Shun Ichiro Taniguchi

Original Assignee

Anaeropharma Science Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-24

Filing date

2005-11-24

Publication date

2011-01-15

2005-11-24 Application filed by Anaeropharma Science Inc filed Critical Anaeropharma Science Inc

2011-01-15 Application granted granted Critical

2011-01-15 Publication of ATE495246T1 publication Critical patent/ATE495246T1/de

Links

239000013605 shuttle vector Substances 0.000 title abstract 4
241000186000 Bifidobacterium Species 0.000 abstract 7
241000588724 Escherichia coli Species 0.000 abstract 4
239000013604 expression vector Substances 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
108020005091 Replication Origin Proteins 0.000 abstract 2
108020004414 DNA Proteins 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
101150073130 ampR gene Proteins 0.000 abstract 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 abstract 1
229960000723 ampicillin Drugs 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
210000004897 n-terminal region Anatomy 0.000 abstract 1
239000013612 plasmid Substances 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Structure Of Belt Conveyors (AREA)
Variable-Direction Aerials And Aerial Arrays (AREA)

AT09003552T 2004-11-24 2005-11-24 Neuartiger shuttle-vektor ATE495246T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2004339677		2004-11-24

Publications (1)

Publication Number	Publication Date
ATE495246T1 true ATE495246T1 (de)	2011-01-15

Family

ID=36498025

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09003552T ATE495246T1 (de)	2004-11-24	2005-11-24	Neuartiger shuttle-vektor

Country Status (13)

Country	Link
US (1)	US8021653B2 (de)
EP (2)	EP2088193B1 (de)
JP (1)	JP4989231B2 (de)
KR (1)	KR101243662B1 (de)
CN (1)	CN101065482B (de)
AT (1)	ATE495246T1 (de)
CA (1)	CA2586126C (de)
DE (1)	DE602005025946D1 (de)
DK (1)	DK2088193T3 (de)
ES (1)	ES2357372T3 (de)
PT (1)	PT2088193E (de)
SG (1)	SG158077A1 (de)
WO (1)	WO2006057289A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8911721B2 (en)	2006-05-24	2014-12-16	Anaeropharma Science, Inc.	Method of constructing gene transport support
AU2008204442B2 (en) *	2007-01-12	2013-03-14	Intrexon Actobiotics Nv	Lactococcus promoters and uses thereof
HUE033561T2 (hu) *	2008-04-17	2017-12-28	Anaeropharma Science Inc	Expresszió vektor
US9730968B2 (en)	2008-04-17	2017-08-15	Anaeropharma Science, Inc.	Therapeutic agent for ischemic diseases
KR101850162B1 (ko)	2010-01-29	2018-04-18	가부시키가이샤 아네로파마·사이엔스	형질전환용 플라스미드
JP6744224B2 (ja)	2014-02-14	2020-08-19	シンヴィヴォコーポレイション	核酸ベクターおよびその使用
CN104388419B (zh) *	2014-10-13	2018-01-16	华侨大学	一种高效扩增核酸分子的方法
US10676723B2 (en)	2015-05-11	2020-06-09	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
EP3380605A1 (de) *	2015-11-24	2018-10-03	GlaxoSmithKline Intellectual Property Development Limited	Transientes transfektionsverfahren zur retroviralen herstellung
JP7098521B2 (ja) *	2015-11-24	2022-07-11	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド	レトロウイルス産生のための安定な細胞株
KR20170068304A (ko)	2015-12-09	2017-06-19	삼성전자주식회사	대장균 및 코마가타에이박터 속 세포에서 복제가능한 벡터, 그를 포함한 세포, 및 그를 이용하는 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS63309191A (ja) *	1987-06-09	1988-12-16	Toagosei Chem Ind Co Ltd	プラスミドベクタ−
US6110737A (en)	1988-02-02	2000-08-29	The Regents Of The University Of California	Human platelet-derived growth factor receptor, type A
JPH05130876A (ja) *	1991-04-10	1993-05-28	Morinaga Milk Ind Co Ltd	プラスミドベクター
US6190657B1 (en)	1995-06-07	2001-02-20	Yale University	Vectors for the diagnosis and treatment of solid tumors including melanoma
JP3946300B2 (ja) *	1997-03-27	2007-07-18	株式会社ヤクルト本社	ビフィズス菌用シャトルベクター及びビフィズス菌プラスミドの複製タンパク質遺伝子
CN1253551C (zh)	1997-09-10	2006-04-26	维昂药品公司	减毒的遗传修饰肿瘤靶向细菌
US6080849A (en)	1997-09-10	2000-06-27	Vion Pharmaceuticals, Inc.	Genetically modified tumor-targeted bacteria with reduced virulence
JPH11285387A (ja) *	1998-04-03	1999-10-19	Tdk Corp	新規なｄｎａ配列及びそれを含むプラスミドベクター
WO2001014579A2 (en)	1999-08-26	2001-03-01	Vion Pharmaceuticals, Inc.	Compositions and methods for delivery of an agent using attenuated salmonella containing phage
US6962696B1 (en)	1999-10-04	2005-11-08	Vion Pharmaceuticals Inc.	Compositions and methods for tumor-targeted delivery of effector molecules
US20020054865A1 (en)	2000-09-21	2002-05-09	Minoru Fujimori	Anaerobic bacterium as a drug for cancer gene therapy
JP3642755B2 (ja)	2000-09-21	2005-04-27	純天野	嫌気性菌を用いた遺伝子治療用医薬
CA2444649C (en) *	2001-04-20	2012-10-02	The Penn State Research Foundation	Methods for nucleic acid manipulation
JP2003235565A (ja) *	2002-02-20	2003-08-26	Yakult Honsha Co Ltd	乳酸菌用シャトルベクター

2005
- 2005-11-24 WO PCT/JP2005/021566 patent/WO2006057289A1/ja not_active Ceased
- 2005-11-24 CN CN2005800400785A patent/CN101065482B/zh not_active Expired - Fee Related
- 2005-11-24 EP EP09003552A patent/EP2088193B1/de not_active Expired - Lifetime
- 2005-11-24 SG SG200907759-5A patent/SG158077A1/en unknown
- 2005-11-24 CA CA2586126A patent/CA2586126C/en not_active Expired - Lifetime
- 2005-11-24 PT PT09003552T patent/PT2088193E/pt unknown
- 2005-11-24 DK DK09003552.8T patent/DK2088193T3/da active
- 2005-11-24 EP EP05809419A patent/EP1829963A4/de not_active Withdrawn
- 2005-11-24 US US11/718,680 patent/US8021653B2/en active Active
- 2005-11-24 AT AT09003552T patent/ATE495246T1/de not_active IP Right Cessation
- 2005-11-24 DE DE602005025946T patent/DE602005025946D1/de not_active Expired - Lifetime
- 2005-11-24 JP JP2006547820A patent/JP4989231B2/ja not_active Expired - Fee Related
- 2005-11-24 KR KR1020077014237A patent/KR101243662B1/ko not_active Expired - Fee Related
- 2005-11-24 ES ES09003552T patent/ES2357372T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2357372T3 (es)	2011-04-25
JP4989231B2 (ja)	2012-08-01
EP2088193B1 (de)	2011-01-12
CA2586126A1 (en)	2006-06-01
DE602005025946D1 (de)	2011-02-24
CN101065482B (zh)	2011-07-13
EP1829963A1 (de)	2007-09-05
EP1829963A4 (de)	2009-01-28
KR20070107671A (ko)	2007-11-07
SG158077A1 (en)	2010-01-29
US8021653B2 (en)	2011-09-20
US20100129323A1 (en)	2010-05-27
CN101065482A (zh)	2007-10-31
DK2088193T3 (da)	2011-02-28
JPWO2006057289A1 (ja)	2008-06-05
CA2586126C (en)	2016-06-28
KR101243662B1 (ko)	2013-03-14
PT2088193E (pt)	2011-02-24
EP2088193A1 (de)	2009-08-12
WO2006057289A1 (ja)	2006-06-01

Legal Events

Date	Code	Title	Description
2011-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE495246T1 (de)	2011-01-15	Neuartiger shuttle-vektor
Sha et al.	2013	Evaluation of the roles played by Hcp and VgrG type 6 secretion system effectors in Aeromonas hydrophila SSU pathogenesis
CA2274982A1 (en)	2000-01-15	New escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
AP1763A (en)	2007-08-02	Pulmonary administration of chemically modified insulin
AR033878A1 (es)	2004-01-07	Clonacion y secuenciamiento de genes de piruvato descarboxilasa (pdc) de bacterias y usos de los mismos
WO2006112930A3 (en)	2007-04-05	Q3 sparc deletion mutant and uses thereof
AU2001254624A1 (en)	2001-11-12	Human coagulation factor vii variants
MXPA02012743A (es)	2003-04-25	Moleculas tipo il-17 y usos de las mismas.
MX2023012131A (es)	2024-01-11	Construcciones de il-2.
WO2001048209A3 (en)	2002-05-02	Genes identified as required for proliferation of e. coli
DK1425038T3 (da)	2006-03-27	Svækkede bakterier, der er anvendelige i vacciner
NO20014537L (no)	2001-10-31	AKT-nukleinsyrer, -polypeptider og anvendelse av disse
Gupta et al.	2001	Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis
Hsiao et al.	2008	Post‐transcriptional cross‐talk between pro‐and anti‐colonization pili biosynthesis systems in Vibrio cholerae
MXPA03004539A (es)	2004-03-26	Luciferasas aisladas y uso de las mismas.
Sanders et al.	2007	Membrane-spanning and periplasmic segments of CcmI have distinct functions during cytochrome c biogenesis in Rhodobacter capsulatus
Hosseini et al.	2020	Targeting of cholera toxin A (ctxA) gene by zinc finger nuclease: pitfalls of using gene editing tools in prokaryotes
Komine et al.	1991	Physical map locations of the genes that encode small stable RNAs in Escherichia coli
WO2001034810A3 (en)	2002-05-10	Genes essential for microbial proliferation
WO2001088137A3 (en)	2002-07-18	Human myd88 adapter-like protein and functional fragments thereof
DE602004029180D1 (de)	2010-10-28	Neue plasmide und deren nutzung
UY26287A1 (es)	2001-03-16	Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1
IL174645A0 (en)	2006-08-20	MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
WO2001088114A3 (en)	2002-06-20	Gene expression system
DE69231682D1 (de)	2001-03-15	Gegen schädlinge der gattung hautflügler aktiver bacillus thuringiensisisolate und für gegen hautflügler aktive toxine kodierende gene